FDA Approves Genentech Medicine for Women with Advanced Cervical Cancer
August 14th, 2014
On August 14, 2014, the FDA approved Avastin® (bevacizumab) in combination with paclitaxel and cisplatin or paclitaxel and topotecan for the treatment of women with persistent, recurrent or metastatic carcinoma of the cervix.
News in brief
- Women with advanced cervical cancer now have the option of Avastin plus chemotherapy to help them live longer than with chemotherapy alone.
- Prior to this approval, chemotherapy was the only approved treatment option for women whose cancer recurred, persisted or spread.
- Avastin is approved in the United States to treat five distinct tumor types.
Additional Important Safety Information
Possible serious side effects
Everyone reacts differently to Avastin therapy. So, it’s important to know what the
side effects are. Although some people may have a life-threatening side
effect, most do not. Your doctor will stop treatment if any serious side effects
occur. Be sure to contact your health care team if there are any signs of
these side effects.
- GI perforation. A hole that develops in your stomach or intestine.
Symptoms include pain in your abdomen, nausea, vomiting, constipation,
- Abnormal passage in the body. This type of passage—known as a fistula—is an irregular connection from one part of the body to another and
can sometimes be fatal
- Wounds that don’t heal. A cut made during surgery can be slow to heal
or may not fully heal. Avastin should not be used for at least 28 days
before or after surgery and until surgical wounds are fully healed
- Serious bleeding. This includes vomiting or coughing up blood; bleeding
in the stomach, brain, or spinal cord; nosebleeds; and vaginal bleeding. If
you recently coughed up blood or had serious bleeding, be sure to tell
- Severe high blood pressure. Blood pressure that severely spikes or
shows signs of affecting the brain. Blood pressure should be monitored
every 2 to 3 weeks while on Avastin and after stopping treatment
- Kidney problems. These may be caused by too much protein in the urine
and can sometimes be fatal
- Infusion-related reactions. These were uncommon with the first dose
(less than 3% of patients). 0.4% of patients had severe reactions. Infusion-related reactions include high blood pressure or severe high blood pressure that may lead to stroke, trouble breathing, decreased oxygen in red blood cells, serious allergic reactions, chest pain, headache, tremors, and excessive sweating. Your doctor or nurse will monitor you for signs of infusion-related reactions
- Severe stroke or heart problems. These may include blood clots,
mini-stroke, heart attack, chest pain, and your heart may become too
weak to pump blood to other parts of your body (congestive heart failure).
These can sometimes be fatal
- Nervous system and vision problems. Signs include headache, seizure,
high blood pressure, sluggishness, confusion, and blindness
Side effects seen most often
In clinical studies across different types of cancer, some patients experienced the
following side effects:
- High blood pressure
- Too much protein in the urine
- Back pain
- Taste change
- Dry skin
- Inflammation of the skin
- Inflammation of the nose
- Watery eyes
Avastin is not for everyone
Talk to your doctor if you are:
- Undergoing surgery. Avastin should not be used for 28 days before or
after surgery and until surgical wounds are fully healed
- Pregnant or think you are pregnant. Data have shown that Avastin may
harm your unborn baby. Use birth control while on Avastin. If you stop
Avastin, you should keep using birth control for 6 months before trying to
- Planning to become pregnant. Taking Avastin could cause a woman’s
ovaries to stop working and may impair her ability to have children
- Breastfeeding. Breastfeeding while on Avastin may harm your baby,
therefore, women should not breastfeed during and for 6 months after
For more information about your treatment or condition, talk to your doctor.
You may report side effects to the FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch. You may also report side effects to Genentech at
Please see full Product Information, including Serious Side Effects, for additional important safety information.
“With this approval, women with advanced cervical cancer now have the option of Avastin plus chemotherapy to help them live longer than with chemotherapy alone. Cervical cancer is most commonly diagnosed in women between the ages of 35 and 44, and until today, chemotherapy was the only approved treatment option for women whose cancer recurred, persisted or spread.”